These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38036414)

  • 1. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
    Schmitto JD; Shaw S; Garbade J; Gustafsson F; Morshuis M; Zimpfer D; Lavee J; Pya Y; Berchtold-Herz M; Wang A; Gazzola C; Potapov E; Saeed D
    Eur Heart J; 2024 Feb; 45(8):613-625. PubMed ID: 38036414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry.
    Zimpfer D; Gustafsson F; Potapov E; Pya Y; Schmitto J; Berchtold-Herz M; Morshuis M; Shaw SM; Saeed D; Lavee J; Heatley G; Gazzola C; Garbade J
    Eur Heart J; 2020 Oct; 41(39):3801-3809. PubMed ID: 33107561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.
    Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto J; Morshuis M; Chuang J; Damme L; Zimpfer D; Garbade J
    Eur Heart J; 2018 Oct; 39(37):3454-3460. PubMed ID: 30165521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.
    Netuka I; Sood P; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Marasco S; Beyersdorf F; Damme L; Schmitto JD
    J Am Coll Cardiol; 2015 Dec; 66(23):2579-2589. PubMed ID: 26670056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
    Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
    Krabatsch T; Netuka I; Schmitto JD; Zimpfer D; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Damme L; Pya Y
    J Cardiothorac Surg; 2017 Apr; 12(1):23. PubMed ID: 28376837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry.
    Garbade J; Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto JD; Morshuis M; Chuang J; Zimpfer D
    Ann Thorac Surg; 2019 Jan; 107(1):33-39. PubMed ID: 30291831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Schmitto JD; Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):834-838. PubMed ID: 27412342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M; Schmitto JD
    Circ Heart Fail; 2020 Mar; 13(3):e006252. PubMed ID: 32164438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.